Article info

Download PDFPDF

Original research
Effectiveness and safety of secukinumab in 608 patients with psoriatic arthritis in real life: a 24-month prospective, multicentre study

Authors

  1. Correspondence to Dr Roberta Ramonda; roberta.ramonda{at}unipd.it
View Full Text

Citation

Ramonda R, Lorenzin M, Carriero A on behalf Spondyloartritis and Psoriatic Arthritis SIR Study Group “Antonio Spadaro”, et al
Effectiveness and safety of secukinumab in 608 patients with psoriatic arthritis in real life: a 24-month prospective, multicentre study

Publication history

  • Received November 13, 2020
  • Revision received January 26, 2021
  • Accepted January 27, 2021
  • First published February 16, 2021.
Online issue publication 
February 16, 2021
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.